PBE
Invesco Dynamic Biotechnology & Genome ETF [PBE] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
PBE Stock Summary
Top 10 Correlated ETFs
PBE
Top 10 Correlated Stocks
PBE
In the News
PBE Financial details
Company Rating
-
Market Cap
278.69M
Income
23.92M
Revenue
1.18M
Book val./share
-
Cash/share
-
Dividend
0.01
Dividend %
0.02%
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
25.66
Forward P/E
-
PEG
-1.97
P/S
325.21
P/B
1.06
P/C
-
P/FCF
-
Quick Ratio
-
Current Ratio
1
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
6.1
EPS next Y
-
EPS next Q
-
EPS this Y
-129.43%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
14.83%
Revenue last 5Y
9.07%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-0.92%
SMA50
-3.51%
SMA100
-3.52%
Inst Own
-
Inst Trans
-
ROA
4%
ROE
4%
ROC
-
Gross Margin
100%
Oper. Margin
-13%
Profit Margin
1120%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
52.47-67.76
52W High
+1.66%
52W Low
+30.98%
RSI
47.81
Rel Volume
0.39
Avg Volume
12.13K
Volume
4.72K
Perf Week
1.85%
Perf Month
0.15%
Perf Quarter
-4.27%
Perf Half Y
-4.9%
-
-
-
-
Beta
0.82
-
-
Volatility
0.26%, 0.81%
Prev Close
-0.37%
Price
68.11
Change
-0.5%
PBE Financial Performance
PBE Frequently Asked Questions
What is Invesco Dynamic Biotechnology & Genome ETF stock symbol ?
Invesco Dynamic Biotechnology & Genome ETF is a US stock and trading under the symbol PBE
What is Invesco Dynamic Biotechnology & Genome ETF stock quote today ?
Invesco Dynamic Biotechnology & Genome ETF stock price is $68.11 today.
Is Invesco Dynamic Biotechnology & Genome ETF stock public?
Yes, Invesco Dynamic Biotechnology & Genome ETF is a publicly traded company.
Company Profile
- Volume Average 12.13K
- Market Capitalization 278.69M
- Headquarters Wheaton,US
- IPO Date 2005-06-23
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying intellidex. The underlying intellidex was composed of common stocks of U.S. biotechnology and genome companies. These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc. It is non-diversified.
